Valtecne SpA

Valtecne SpA EBIT Margin

The EBIT Margin (Operating Margin) of Valtecne SpA (VLT.MI) as of Oct 22, 2026 is 16.07 %. In the previous year, EBIT Margin (Operating Margin) was 14.62 % — a change of 9.92% (higher).

EBIT Margin

16.07 %

YoY

9.92%

Last updated:

EBIT Margin (Operating Margin) of Valtecne SpA is 2025 16.07 % . EBIT Margin (Operating Margin) of Valtecne SpA was 2024 14.62 % . It decreases by 9.92% higher compared to the previous year.

Valtecne SpA's operating (EBIT) margin stands at 16.1%, up from 10.6% several years earlier.

The Valtecne SpA EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
12.04 EUR
Jan 1, 2020
7.12 EUR
Jan 1, 2021
10.56 EUR
Jan 1, 2022
13.32 EUR
Jan 1, 2023
14.07 EUR
Jan 1, 2024
14.62 EUR
Jan 1, 2025
16.07 EUR
The Valtecne SpA EBIT Margin history
YEAREBIT MarginYoY
16.07 %+9.92%
14.62 %+3.91%
14.07 %+5.64%
13.32 %+26.09%
10.56 %+48.47%
7.12 %-40.91%
12.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valtecne SpA Stock analysis

What does Valtecne SpA do? Valtecne SpA produces precision-machined mechanical components for orthopedic and veterinary surgery, including cutting guides, pin pliers, femoral sizers, and tibial resection guides. The company also manufactures implantable devices such as femoral stems, femoral heads, stem collars, and tibial implants. These products are sold globally to medical device manufacturers and healthcare providers specializing in orthopedic and veterinary care. Valtecne SpA generates revenue through the sale of these high-precision surgical instruments and implantable devices to international medical markets. The company operates in the precision-machined sector, focusing on specialized instruments for orthopedic and veterinary surgery. Its product range includes both surgical tools like cutting guides and implantable components such as femoral stems. Valtecne SpA's global operations ensure its products reach medical device companies and clinics worldwide, supporting the production of advanced surgical solutions. Valtecne SpA's revenue model is based on manufacturing and selling precision-machined components for medical applications. The company's key products are surgical instruments and implantable devices used in orthopedic and veterinary procedures. By targeting medical device manufacturers and healthcare providers, Valtecne SpA secures contracts for its high-precision components, which are essential for surgical procedures and patient care. Valtecne SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valtecne SpA stock

EBIT Margin (Operating Margin) of Valtecne SpA is 16.07 % in 2025.

EBIT Margin (Operating Margin) of Valtecne SpA changed from 14.62 % to 16.07 %, representing a 9.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Valtecne SpA since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Valtecne SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Valtecne SpA

All Key Metrics — Valtecne SpA